Johnson Investment Counsel’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Buy
8,320
+350
+4% +$23K ﹤0.01% 588
2026
Q1
$567K Sell
7,970
-7,942
-50% -$626K ﹤0.01% 553
2025
Q4
$1.31M Sell
15,912
-7,015
-31% -$547K 0.01% 369
2025
Q3
$1.72M Buy
22,927
+127
+0.6% +$9.47K 0.01% 325
2025
Q2
$1.69M Sell
22,800
-1
-0% -$70 0.02% 331
2025
Q1
$1.84M Sell
22,801
-290
-1% -$24.9K 0.02% 306
2024
Q4
$1.81M Buy
23,091
+382
+2% +$32.5K 0.02% 304
2024
Q3
$2.13M Buy
22,709
+1,184
+6% +$99.4K 0.02% 278
2024
Q2
$1.68M Buy
21,525
+458
+2% +$37.4K 0.02% 301
2024
Q1
$1.92M Sell
21,067
-522
-2% -$43.4K 0.02% 281
2023
Q4
$1.67M Sell
21,589
-125
-0.6% -$8.75K 0.02% 285
2023
Q3
$1.48M Sell
21,714
-57
-0.3% -$4.15K 0.02% 294
2023
Q2
$1.77M Sell
21,771
-421
-2% -$33.6K 0.02% 267
2023
Q1
$1.82M Buy
+22,192
New +$1.58M 0.02% 259

Other funds holding GEHC

Johnson Investment Counsel's GEHC Position: Q2 2026 in Review

Johnson Investment Counsel increased its GE HealthCare (GEHC) stake by 4.4% in Q2 2026, buying an estimated $23K and bringing the position to 8,320 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Johnson Investment Counsel first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.13M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Johnson Investment Counsel held 8,320 shares of GE HealthCare worth $533K as of Q2 2026.
  • Johnson Investment Counsel bought 350 GE HealthCare shares in Q2 2026, an estimated $23K.
  • GE HealthCare made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #588 holding.
  • Johnson Investment Counsel first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Johnson Investment Counsel's GE HealthCare position peaked at $2.13M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.